Investor Relations & Capital Introduction in Basel

Basel sits on the Rhine where Switzerland, France and Germany meet, and is one of the world's most important centres of pharmaceuticals and life sciences. For founders in biotechnology and health, it offers global corporate partners, specialist investors and deep scientific talent.

Why Basel Matters for Capital Raising

Novartis and Roche, two of the world's largest pharmaceutical companies, are both headquartered in Basel, and their corporate venture arms are active investors in biotechnology.

The Bank for International Settlements, founded in 1930 and often described as the central bank for central banks, is based in Basel, alongside a substantial private banking and wealth community.

The University of Basel, founded in 1460, is Switzerland's oldest university, and the city hosts Art Basel, one of the world's leading art fairs.

What Basel Investors Examine

For life sciences businesses, scientific data, clinical strategy and intellectual property are examined closely.

Investors value experienced teams and clear partnering or exit pathways with large pharmaceutical companies.

Engagement and Access

GCN connects founders with Basel life sciences investors, corporate venture funds and family offices through conference programming and private sessions across Switzerland.

Sectors where we see consistent Basel interest include biotechnology, pharmaceuticals, medical technology, digital health and chemicals.

Partner with Global Capital Network

Whether you are raising into Basel or allocating from it, our team can discuss how our investor relations infrastructure applies to your objectives.